Wearable Ultrasound Probe Enables User To See, Feel, And Do

Sonivate Medical’s finger-worn ultrasound imaging probe is a ground-breaking solution that is perfectly positioned to satisfy the growing demand for point-of-care diagnostics, as well as "wearable" technology.

The global market for ultrasound devices and services is sizeable at around $7 billion spent per year worldwide on machines and accessories. An estimated 430 million scans are performed annually on 450,000 million systems, and Sonivate Medical Inc., an Oregon-based start-up company, has its finger on the pulse of this burgeoning field with the SonicEye, an ultrasound imaging probe that is actually worn on the user’s finger. According to Sonivate president and CEO David Starr, the market for ultrasound probes alone is worth around $1.4 billion annually. Starr says one of the main advantages of the SonicEye probe is that it leverages innate human hand/eye coordination to provide both fine-motor positional control and exquisite spatial awareness of fingertip location with tactile feedback. “We have taken existing ultrasound transducer [aka probe] technology and miniaturized it and put a hole in the middle so it can be worn on the finger. It has the same image quality and imaging characteristics as traditional ultrasound transducers, but by changing the form it facilitates greater ease of use and is much easier and more intuitive to learn how to use,” he says.

The probe, which received FDA clearance in 2012, supports applications in ultrasound-guided needle procedures including vascular access, needle aspiration, and nerve blocks, among other things. It is also being developed...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Surgical Procedures

SS Innovations Files For De Novo For SSi Mantra 3 Surgical Robotic System For Multispecialty Indications

 
• By 

SS Innovations announced plans to file a de novo application with the US FDA for its SSi Mantra 3 surgical robot, already approved for marketing in six countries. The Florida-based firm also plans to pursue the CE mark for European commercialization.

California Medtech Firms Resolve Patent Dispute Over Delivery Catheters

 

Route 92 says it has reached a settlement with Q’Apel Medical over patent claims concerning its Tenzing delivery catheters.

AAOS 2025 Orthopedic Roundup: J&J Velys UKA, Stryker Mako 4, Materialise, Canary Medical

 
• By 

At AAOS, orthopedics players showcased their latest robotic-assisted platforms, power tools, 3D printed technologies and software offerings. This article brings you highlights from interviews Medtech Insight conducted on site with representatives from J&J, Stryker, Materialise and Canary Medical.

Medtronic Presents Data To Boost Hugo’s Odds Of Getting FDA Nod

 

Medtronic says results from a recent study on the Hugo robotic-assisted surgery system substantiate its safety and effectiveness for various urological procedures. The company also announced it has submitted the system to the FDA for approval for a urological indication.

More from Surgery

Medtronic Presents Data To Boost Hugo’s Odds Of Getting FDA Nod

 

Medtronic says results from a recent study on the Hugo robotic-assisted surgery system substantiate its safety and effectiveness for various urological procedures. The company also announced it has submitted the system to the FDA for approval for a urological indication.

HRS Released Framework For Afib Center Of Excellence To Improve Outcomes Through Multidisciplinary Care

 
• By 

Medtech Insight sat down with Jared Bunch, chair of AF Center of Excellence Task Force, at HRS 2025 to discuss the newly HRS released framework for Afib Center of Excellence and get his perspective on the role industry could play to help clinicians improve patient outcomes.

Q’Apel Medical Recalls, Discontinues Stroke Therapy System After FDA Warning Letter, Class I Designation

 

Q’Apel Medical has pulled its aspiration system for stroke thrombectomy from the market after concerns raised by the US FDA in a February warning letter.